Insilico Medicine
PulseAugur coverage of Insilico Medicine — every cluster mentioning Insilico Medicine across labs, papers, and developer communities, ranked by signal.
2 day(s) with sentiment data
-
METiS TechBio debuts on Hong Kong stock market with AI-driven drug delivery tech
METiS TechBio, a Hong Kong-listed biotech firm, has successfully debuted on the stock market, with its shares surging significantly on its first day of trading. The company utilizes artificial intelligence to design and…
-
AI models show growing bio-synthesis power, sparking misuse fears
AI models are demonstrating increasing capabilities in biological synthesis, raising concerns about potential misuse for creating dangerous pathogens. While current models are not yet capable of independently generating…
-
Eli Lilly bets $2.75B on AI-designed drugs, signaling pharma's AI shift
Eli Lilly has invested $2.75 billion in Insilico Medicine, a Hong Kong-based company that uses AI for drug discovery. This significant deal highlights the growing trend of major pharmaceutical companies committing subst…
-
AI models show potential to match or exceed doctor capabilities for basic health questions
Experts suggest consumers should increase their use of AI for health-related inquiries, as certain AI models demonstrate capabilities comparable to or exceeding those of doctors for basic health questions. While AI is a…